Top U.S. Marijuana Stocks to Watch in October 2025The U.S. cannabis industry continues to show remarkable strength as legalization momentum grows nationwide. Analysts project the market will exceed $45 billion by 2025, reflecting strong consumer demand and expanding state-level access. In addition, the cannabis sector supports over 400,000 full-time jobs and contributes billions in tax revenue each year. Recent headlines suggest the federal government may soon revisit reclassification, fueling optimism amon ...

Key Points Tilray stock rocketed on Monday on rumors the U.S. might legalize marijuana soon. In Germany, Tilray is expanding medical marijuana production. Tilray is losing a lot of money even as its other news turns good. 10 stocks we like better than Tilray Brands › Tilray Brands (NASDAQ: TLRY) stock rocketed on Monday, soaring more than 60% after President Donald Trump posted a video on his Truth Social account promoting marijuana legalization to treat ailing senior citizens -- and covering the ...

Key Points President Trump posted a pro-marijuana video on Truth Social yesterday. Curaleaf stock promptly leapt 37%. The stock's giving back some gains today, but still looks expensive. 10 stocks we like better than Curaleaf › Curaleaf Holdings (OTC: CURLF) stock, an over-the-counter traded, Stamford, Conn.-based cannabis company, tumbled 5.9% through 11:40 a.m. ET Tuesday after soaring 37% on Monday. I don't think investors need to worry too much about the retreat, however. It looks to me a lot ...

Cannabis stocks have been on an absolute tear in the past month as investors are optimistic that marijuana will soon be legalized at the federal level in the U.S. Curaleaf (CURLF) stock has surged nearly 90% year-to-date, making it the top performer among pot stocks tracked by Barchart. The rally intensified on Monday after President Trump suggested marijuana reclassification could happen within weeks and praised CBD's potential for senior healthcare. The broader market responded enthusiastically, with th ...

Group 1 - The cannabis industry, including multi-state operator Cresco Labs, is facing significant challenges such as black- and gray-market competition, limited access to financial services, and high taxation [1][2] - Cresco Labs' stock performance has been poor, with a $1,000 investment in the stock shrinking to approximately $200 over the past five years, while the S&P 500 index would have grown to $1,878 in the same period [2] - The legal status of cannabis in the U.S. is complicated, with federal illegality contrasted by varying state laws, leading to a patchwork of legalization across the country [4] Group 2 - There is ongoing lobbying for federal rescheduling of marijuana, but it is not a priority for lawmakers, leaving companies like Cresco in a survival mode [5] - Cresco Labs is experiencing declining revenue and ongoing challenges with profitability, although it has recently refinanced a $325 million credit facility and holds $147 million in cash and equivalents [6]

Core Viewpoint - The marijuana industry is currently facing challenges, but Trulieve Cannabis is positioned as a potential contrarian investment opportunity despite its recent struggles [1][2]. Company Performance - Trulieve's stock has significantly declined, with a $1,000 investment three years ago now worth approximately $610 [2]. - In the second quarter, Trulieve reported a non-GAAP adjusted net loss of $8 million, compared to breakeven the previous year, while maintaining revenue at $302 million [3]. - The company has opened three new dispensaries during the quarter, two in Florida and one in Ohio, indicating ongoing expansion [4]. Financial Health - Trulieve is cash flow-positive, with cash, equivalents, and restricted cash increasing by nearly 13% year over year to $401 million [4]. Industry Outlook - There is potential for reform in marijuana laws, with ongoing discussions about decriminalization by the DEA and a financial services reform bill, supported by public demand for change [5]. - Long-term investors in Trulieve are expected to see rewards as the industry evolves [6].